Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Skin test could warn of hidden blood vessel trouble

NCT ID NCT04777383

Knowledge-focused Sponsor: University Hospital, Linkoeping Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how tiny blood vessels in the skin of healthy volunteers respond to substances that make them widen or narrow. Researchers used a mild electrical current to deliver these substances through the skin and measured changes in blood flow with light. The goal was to better understand blood vessel function and find ways to detect early signs of diseases like diabetes or heart problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

31 people

The number who actually took part.

Started

Apr 2019

Finished

Oct 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy * No ongoing medication * No skin disease or other skin afflictions * Informed, voluntary participation Exclusion Criteria: * Ongoing medication (contraceptives excluded) * Hypertonia, skin disease or skin afflictions, cardiovascular disease, pregnancy * Damaged skin, bruises, scar tissue or tattoos on the skin of the forearms * Smoking (6 months prior to study onset, or more than 100 cigarettes in life) * Snus (6 months prior to study onset) * Use of nicotine products (gum, patch, et cetera) 6 months prior to study onset * Blood pressure above 140/90 * Coffee, tea, alcohol or strenuous physical activity on the day of the study * Not fasting for 2 hours prior onset of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases Vascular diseases

Contacts and locations

Locations

  • University Hospital Linköping

    Linköping, Östergötland County, 58185, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.